Oak­tree cre­ates third life sci­ences SPAC, fol­low­ing suc­cess with Hims & Hers and Alvotech

Glob­al in­vest­ment man­ag­er Oak­tree is out with its third life sci­ences-ded­i­cat­ed spe­cial pur­pose ac­qui­si­tion com­pa­ny af­ter pre­vi­ous­ly us­ing blank checks to take pub­lic

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER